🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Zipalertinib Placebo Tablets is a film-coated tablet that does not contain the active ingredient, zipalertinib., Cisplatin Hikma 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Zipalertinib, Pemetrexed Fresenius Kabi 25 mg/ml concentrate for solution for infusion, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Taiho Pharma Netherlands B.V.

    Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations

    phase 3 small molecule active

    1 trial

  2. ZoMaxx™ Drug-Eluting Coronary Stent System

    Abbott Australasia Pty Ltd

    Coronary Disease

    phase 3 other completed

    1 trial

  3. Zoladex 3,6 mg implante en jeringa precargada, Decapeptyl semestral 22,5 mg polvo y disolvente para suspensión de liberación prolongada inyectable., Eligard semestral 45 mg polvo y disolvente para solución inyectable., Bicalutamida Aristo 50 mg comprimidos recubiertos con película EFG

    The George Institute

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  4. Zometa 4 mg/100 ml solution for infusion, XGEVA 120 mg solution for injection in pre-filled syringe

    CERO THERAPEUTICS HOLDINGS, INC.

    Patients, men or women over 18 old, with inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy

    phase 3 small molecule active

    1 trial

  5. Zovirax 50 mg/g crema, Lipovir 50 mg/g Gel, Placebo

    Lacuna Pharma Pty Ltd

    Recurrent herpes labialis (RHL)

    phase 3 small molecule active

    1 trial

  6. Zydelig 100 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Truxima 500 mg concentrate for solution for infusion, Truxima 500 mg concentrate for solution for infusion, Truxima 500 mg concentrate for solution for infusion, Zydelig 100 mg film-coated tablets, Bendamustin Hikma 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Bendamustin Hikma 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer I

    Lacuna Pharma Pty Ltd

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  7. abamectin and fenpyroximate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule terminated

    1 trial

  8. adalimumab

    AbbVie

    Pyoderma Gangrenosum

    phase 3 small molecule completed

    1 trial

  9. aflibercept 8 mg PFS

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    phase 3 small molecule completed

    1 trial

  10. agalsidase alfa

    Takeda

    Fabry Disease

    phase 3 mab completed

    3 trials

  11. albiglutide + insulin glargine

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    phase 3 mab completed

    1 trial

  12. alirocumab SAR236553 (REGN727)

    Regeneron UK Limited

    Hypercholesterolemia

    phase 3 small molecule completed

    8 trials

  13. alirocumab SAR236553 (REGN727)

    Regeneron UK Limited

    Hypercholesterolaemia

    phase 3 small molecule completed

    2 trials

  14. alosetron

    GlaxoSmithKline

    Irritable Colon

    phase 3 small molecule completed

    1 trial

  15. bamlanivimab 7000mg

    SAB Biotherapeutics

    Coronavirus

    phase 3 mab completed

    1 trial

  16. bapineuzumab

    Pfizer

    Alzheimer Disease

    phase 3 small molecule terminated

    1 trial

  17. bevacizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Disease Free Survival

    phase 3 small molecule active

    1 trial

  18. bevacizumab

    Outlook Therapeutics NL B. V.

    Age-related Macular Degeneration

    phase 3 mab active

    4 trials

  19. bevacizumab

    Outlook Therapeutics NL B. V.

    Neovascular Age-related Macular Degeneration

    phase 3 mab completed

    1 trial

  20. bicyclol, 25mg/ tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-Induced Acute Liver Injury

    phase 3 small molecule active

    1 trial

  21. bimekizumab

    Lacuna Pharma Pty Ltd

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  22. bimekizumab

    Lacuna Pharma Pty Ltd

    Axial Spondyloarthritis

    phase 3 small molecule active

    1 trial

  23. bimekizumab

    Lacuna Pharma Pty Ltd

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  24. bimekizumab

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources